Corcept Therapeutics CORT Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $109.99M-9.7% | $121.75M-2.7% | $125.14M+21.8% | $102.75M+13.1% | $90.82M-29.4% | ||
| $229.45M-8.8% | $251.66M-15.1% | $296.55M+23.8% | $239.48M+2.8% | $232.94M-8.9% | ||
| $1.25M— | —— | —— | —— | $1M— | ||
| $39.07M-34.6% | $59.79M-14.1% | $69.63M+7.8% | $64.57M+4.4% | $61.82M+14.5% | ||
| $14.51M+30.8% | $11.09M-7.6% | $12M+50.2% | $7.99M+585% | $1.17M-67.5% | ||
| $35.89M-11.7% | $40.66M+8.5% | $37.47M+55.8% | $24.04M-39.2% | $39.55M+80.8% | ||
| $4.2M-71.2% | $14.6M+2.8% | $14.2M— | —— | —— | ||
| $426.03M-12.2% | $485.46M-10.3% | $541.13M+22.1% | $443.11M+1.1% | $438.5M-7.0% | ||
| $3.17M+67.8% | $1.89M-9.7% | $2.09M-10.8% | $2.35M-7.7% | $2.54M-5.4% | ||
| 8.3%-458,299,992% | 458,300,000%+458,299,992% | 8.5%0.0% | 8.5%0.0% | 8.5%-532,399,992% | ||
| $5.15M0.0% | $5.15M-36.0% | $8.05M-3.1% | $8.3M+25.6% | $6.61M0.0% | ||
| $490.93M-4.1% | $511.7M+2.4% | $499.49M+3.1% | $484.56M-12.0% | $550.65M-4.1% | ||
| $814.88M-2.6% | $836.65M+1.6% | $823.61M+2.7% | $801.72M-5.3% | $846.46M+0.7% | ||
| $33.31M-17.6% | $40.44M+17.4% | $34.45M+46.4% | $23.53M-15.8% | $27.95M+81.8% | ||
| $80.16M-11.5% | $90.6M-16.5% | $108.45M+19.1% | $91.07M+2.5% | $88.88M-2.0% | ||
| $1.63M+50.1% | $1.08M+3.2% | $1.05M+3.2% | $1.02M+3.4% | $984K+18.7% | ||
| $3.7M-9.8% | $4.1M— | —— | —— | $4.4M+7.3% | ||
| $149.19M-10.2% | $166.09M-3.6% | $172.27M+19.1% | $144.66M+1.1% | $143.07M+1.6% | ||
| $8.01M+59.5% | $5.02M-5.4% | $5.31M-5.0% | $5.59M-4.5% | $5.85M-4.2% | ||
| $9.64M+57.8% | $6.11M-3.9% | $6.36M-3.7% | $6.61M-3.4% | $6.84M-1.5% | ||
| $176.89M-6.3% | $188.85M-1.5% | $191.71M+15.5% | $165.93M+1.7% | $163.17M+1.4% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $141K+0.7% | $140K+0.7% | $139K+0.7% | $138K+0.7% | $137K+0.7% | ||
| $1B+3.4% | $968.6M+3.7% | $933.61M+3.6% | $900.86M+4.4% | $862.87M+3.7% | ||
| $611.63M-4.9% | $643.39M+3.9% | $619.1M+3.3% | $599.43M+6.2% | $564.28M+3.8% | ||
| $918K-59.5% | $2.26M-3.3% | $2.34M+2.2% | $2.29M+231% | $692K+419% | ||
| $976.69M+1.0% | $966.59M+4.7% | $923.29M+6.5% | $866.93M+16.4% | $744.69M+7.0% | ||
| $637.99M-1.5% | $647.81M+2.5% | $631.9M-0.6% | $635.79M-7.0% | $683.29M+0.5% | ||
| $814.88M-2.6% | $836.65M+1.6% | $823.61M+2.7% | $801.72M-5.3% | $846.46M+0.7% | ||
| $229.45M-8.8% | $251.66M-15.1% | $296.55M+23.8% | $239.48M+2.8% | $232.94M-8.9% | ||
| $6.38M-10.2% | $7.1M+18.4% | $6M-19.7% | $7.47M-70.0% | $24.87M+309% | ||
| $177.26M+10.6% | $160.27M+56.3% | $102.56M-40.6% | $172.78M-30.3% | $248.04M+12.8% | ||
| $5.15M0.0% | $5.15M-36.0% | $8.05M-3.1% | $8.3M+25.6% | $6.61M0.0% | ||
| $7.2M+57.0% | $4.58M-4.0% | $4.78M-3.8% | $4.96M-3.6% | $5.15M-3.3% | ||
| $181.56M+7.9% | $168.2M+9.9% | $153M-5.7% | $162.23M+12.3% | $144.45M+10.3% | ||
| $177.26M+10.6% | $160.27M+56.3% | $102.56M-40.6% | $172.78M-30.3% | $248.04M+12.8% | ||
| $7.2M+57.0% | $4.58M-4.0% | $4.78M-3.8% | $4.96M-3.6% | $5.15M-3.3% | ||
| $5.15M0.0% | $5.15M-36.0% | $8.05M-3.1% | $8.3M+25.6% | $6.61M0.0% | ||
| $7.2M+57.0% | $4.58M-4.0% | $4.78M-3.8% | $4.96M-3.6% | $5.15M-3.3% | ||
| $5.15M0.0% | $5.15M-36.0% | $8.05M-3.1% | $8.3M+25.6% | $6.61M0.0% | ||
| $0— | —— | $0— | $0— | $0— | ||
| $13.59M+28.1% | $10.61M+19.0% | $8.92M+26.6% | $7.04M+67.8% | $4.2M+25.5% | ||
| $80.16M-11.5% | $90.6M-16.5% | $108.45M+19.1% | $91.07M+2.5% | $88.88M-2.0% | ||
| $34.09M+0.4% | $33.95M— | —— | —— | $25.26M-25.4% | ||
| $80.16M-11.5% | $90.6M-16.5% | $108.45M+19.1% | $91.07M+2.5% | $88.88M-2.0% | ||
| $1.69M— | —— | $382K-50.0% | $764K-32.7% | $1.14M— | ||
| $2.78M— | —— | $1.6M0.0% | $1.6M0.0% | $1.6M— | ||
| $1.45M— | —— | $1.7M0.0% | $1.7M0.0% | $1.7M— | ||
| $2.78M— | —— | $1.6M0.0% | $1.6M0.0% | $1.6M— | ||
| $2.86M— | —— | $1.65M0.0% | $1.65M0.0% | $1.65M— | ||
| $1.45M— | —— | $1.7M0.0% | $1.7M0.0% | $1.7M— | ||
| $2.7M— | —— | $1.55M0.0% | $1.55M0.0% | $1.55M— | ||
| $11.48M— | —— | $7.73M-4.7% | $8.11M-4.4% | $8.49M— | ||
| $1.84M— | —— | $1.37M-8.9% | $1.51M-8.5% | $1.65M— | ||
| $2.86M— | —— | $1.65M0.0% | $1.65M+91.4% | $860K— | ||
| $1.45M— | —— | $1.7M0.0% | $1.7M0.0% | $1.7M— | ||
| $13.59M+28.1% | $10.61M+19.0% | $8.92M+26.6% | $7.04M+67.8% | $4.2M+25.5% | ||
| $9.64M+57.8% | $6.11M-3.9% | $6.36M-3.7% | $6.61M-3.4% | $6.84M-1.5% | ||
| $1B+3.4% | $968.6M+3.7% | $933.61M+3.6% | $900.86M+4.4% | $862.87M+3.7% | ||
| $20.87M-44.2% | $37.4M+6.0% | $35.28M+34.3% | $26.28M-27.8% | $36.42M-12.7% | ||
| $33.56M-5.9% | $35.68M-33.1% | $53.34M+4.9% | $50.87M+15.0% | $44.23M+6.4% | ||
| $15.33M+1.0% | $15.18M+7.4% | $14.13M-9.9% | $15.68M+10.0% | $14.25M+1.2% | ||
| $5.24M0.0% | $5.24M+111% | $2.48M0.0% | $2.48M+36.4% | $1.82M0.0% | ||
| $490.93M-4.1% | $511.7M— | —— | —— | $550.65M-4.1% | ||
| $4.41M-12.8% | $5.06M-15.8% | $6.01M+36.6% | $4.4M+2.0% | $4.32M-3.9% | ||
| $27.4M+14.3% | $23.96M-1.6% | $24.35M+20.2% | $20.27M+30.5% | $15.53M-2.9% | ||
| $14.69M+56.1% | $9.41M+9.4% | $8.6M+27.9% | $6.72M-20.9% | $8.5M+3.6% | ||
| $894K+5.5% | $847K-45.4% | $1.55M-11.1% | $1.75M— | —— | ||
| $11.81M-13.8% | $13.7M-3.5% | $14.2M+20.3% | $11.8M+67.7% | $7.04M-9.7% | ||
| $11.48M— | —— | $7.73M-4.7% | $8.11M-4.4% | $8.49M— | ||
| $1.84M— | —— | $1.37M-8.9% | $1.51M-8.5% | $1.65M— | ||
| —— | 40.9K— | —— | —— | —— | ||
| $4.37M+70.5% | $2.56M— | —— | —— | —— | ||
| $0— | —— | $0— | $0— | $0— | ||
| —— | $1M— | —— | —— | —— | ||
| $0.08— | —— | $0.090.0% | $0.090.0% | $0.09— | ||
| $12.14M+75.6% | $6.91M-36.6% | $10.91M+58.5% | $6.88M+71.0% | $4.03M-0.4% | ||
| $19.86M-14.6% | $23.26M+1.2% | $22.98M+137% | $9.69M+13.3% | $8.55M-9.9% | ||
| $10.2M— | —— | —— | —— | —— | ||
| 1.5K— | —— | —— | —— | —— | ||
| $10.2M— | —— | —— | —— | —— | ||
| $1.69M— | —— | $382K-50.0% | $764K-32.7% | $1.14M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Corcept Therapeutics's total assets?
- Corcept Therapeutics (CORT) holds $814.9M in total assets, down 3.7% year over year.
- How much debt does Corcept Therapeutics have?
- Corcept Therapeutics carries $9.6M in total debt against $638.0M of shareholders' equity, a debt-to-equity ratio of 0.02.
- How much cash does Corcept Therapeutics have?
- Corcept Therapeutics holds $110.0M in cash and equivalents.
- Can Corcept Therapeutics cover its short-term obligations?
- Its current ratio is 2.86 — current assets exceed current liabilities.
- Where does Corcept Therapeutics's balance sheet data come from?
- Every line is extracted from Corcept Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
